These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 2876373)
21. Maintenance therapy for opioid addiction with methadone, LAAM and buprenorphine: the Emperor's New Clothes Phenomenon. Stimmel B J Addict Dis; 2001; 20(4):1-5. PubMed ID: 11760922 [No Abstract] [Full Text] [Related]
22. A pilot study of naltrexone-accelerated detoxification in opioid dependence. Bell JR; Young MR; Masterman SC; Morris A; Mattick RP; Bammer G Med J Aust; 1999 Jul; 171(1):26-30. PubMed ID: 10451668 [TBL] [Abstract][Full Text] [Related]
23. [Methadone treatment of narcotic addicts--can it be defended?]. Sundby P Tidsskr Nor Laegeforen; 1991 Dec; 111(30):3730. PubMed ID: 1780841 [No Abstract] [Full Text] [Related]
24. A study of the use of clonidine and naltrexone in the treatment of opioid addiction in the former USSR. Azatian A; Papiasvilli A; Joseph H J Addict Dis; 1994; 13(1):35-52. PubMed ID: 8018739 [TBL] [Abstract][Full Text] [Related]
25. Can psychotherapy rescue naltrexone treatment of opioid addiction? Rounsaville BJ NIDA Res Monogr; 1995; 150():37-52. PubMed ID: 8742771 [No Abstract] [Full Text] [Related]
26. Opiate addiction and the locus coeruleus. The clinical utility of clonidine, naltrexone, methadone, and buprenorphine. Gold MS Psychiatr Clin North Am; 1993 Mar; 16(1):61-73. PubMed ID: 8456048 [TBL] [Abstract][Full Text] [Related]
27. The sequential use of clonidine and naltrexone in the treatment of opiate addicts. Gold MS; Dackis CA; Washton AM Adv Alcohol Subst Abuse; 1984; 3(3):19-39. PubMed ID: 6388273 [TBL] [Abstract][Full Text] [Related]
28. Serious adverse events in the Australian National Evaluation of Pharmacotherapies for Opioid Dependence (NEPOD). Digiusto E; Shakeshaft A; Ritter A; O'Brien S; Mattick RP; Addiction; 2004 Apr; 99(4):450-60. PubMed ID: 15049745 [TBL] [Abstract][Full Text] [Related]
35. Medicalising the treatment of opioid dependence. Peh LH; Ng BY Ann Acad Med Singap; 2006 Jul; 35(7):447-9. PubMed ID: 16902718 [No Abstract] [Full Text] [Related]
36. [Differences in depression severity and frequency of relapses in opiate addicts treated with methadone or opiate blocker after detoxification]. Jovanović T; Lazarević D; Nikolić G Vojnosanit Pregl; 2012 Apr; 69(4):326-32. PubMed ID: 22624424 [TBL] [Abstract][Full Text] [Related]
37. Ambulatory opiate detoxification and primary care: a role for the primary care physician. O'Connor PG; Waugh ME; Schottenfeld RS; Diakogiannis IA; Rounsaville BJ J Gen Intern Med; 1992; 7(5):532-4. PubMed ID: 1403211 [TBL] [Abstract][Full Text] [Related]
38. Outpatient detoxification of heroin addiction, 1969--1973 (methadone, darvon, codeine, clonidine). Rappolt RT; Lawrence F Clin Toxicol; 1979; 14(1):141-2. PubMed ID: 436383 [No Abstract] [Full Text] [Related]
39. Three methods of opioid detoxification in a primary care setting. A randomized trial. O'Connor PG; Carroll KM; Shi JM; Schottenfeld RS; Kosten TR; Rounsaville BJ Ann Intern Med; 1997 Oct; 127(7):526-30. PubMed ID: 9313020 [TBL] [Abstract][Full Text] [Related]
40. Update on pharmacotherapy for treatment of opioid use disorder. Ayanga D; Shorter D; Kosten TR Expert Opin Pharmacother; 2016 Dec; 17(17):2307-2318. PubMed ID: 27734745 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]